podcasts.apple.com/us/podcast/l... truly a pleasure to discuss @iaslc.bsky.social policy alongside former attending @stephenvliu.bsky.social ! It takes a village to move agenda forward alongside @andreascharalambous.xyz and @nicolerankin.bsky.social take a listen now!
It was an honor to share the stage with colleagues from Ireland, India, Japan, Austria, and South Africa discussing workforce challenges, resource limitations, and expanding access to care globally in our #GlobalPolicyandPartnerships session
Reflecting on a data-packed
@iaslc.bsky.social #WCL25 with non-clinical panels on Narrowing Disparities in Effective Management of Lung Cancer on the Global Scale and the
@who.int
#IntegratedLungHealthResolution stand out most--time to bring these findings home!
The MARIPOSA effect 🦋
‼️Awaited OS data for #Amivantamab + lazertinib vs osimertinib in 1L EGFRm advanced #lungcancer presented at #ELCC25
🎯OS HR 0.75 (95%CI: 0.61-0.92)
🎉> 1 yr mOS advantage
🚫no crossover allowed, ⬆️intracranial activity
⬇️toxicity over time w prophylactic mgmt (skin)
#lcsm
Join us today at noon EST for free #PatientEducation to discuss all things new in the management of Colorectal Cancers @BHCancerCare @BaptistHealthSF @MiamiCancerInst
#CRCSM #PatientEducation
3 points of progress vs pancreatic cancer!
1. Neoantigen vaccines
www.nature.com/articles/s41...
2. KRAS drugs
www.wsj.com/health/healt...
3. Early diagnosis www.science.org/doi/10.1126/...
First lecture as faculty yesterday to the @FAUCollegeofMedicine + @WPBVAHCS Pulmonology team. 🫁 cancers are still a team sport in 2025 and beyond! @iaslc.bsky.social @ascocancer.bsky.social @FLASCO_ORG @BHCancerCare